|
 
The U.S. Food and Drug Administration (FDA) is announcing planned 2024 annual enhancements to the Electronic Medical Device Reporting (eMDR) System. This notice is to allow manufacturers who submit reports using AS2 (system-to-system) early notice about the planned eMDR system enhancements.
The 2024 list of enhancements and the schedule for deployment is available on the eMDR System Enhancements web page.
Questions?
Please contact the eMDR helpdesk at eMDR@fda.hhs.gov for any questions or concerns about enhancements.
|
|
|
|
